First National Bank of South Miami’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-200
Closed -$49K 279
2022
Q3
$49K Hold
200
0.04% 189
2022
Q2
$50K Hold
200
0.03% 197
2022
Q1
$66K Hold
200
0.04% 207
2021
Q4
$72K Hold
200
0.04% 200
2021
Q3
$65K Hold
200
0.04% 194
2021
Q2
$62K Hold
200
0.04% 196
2021
Q1
$64K Hold
200
0.05% 174
2020
Q4
$65K Hold
200
0.06% 171
2020
Q3
$55K Hold
200
0.05% 167
2020
Q2
$48K Hold
200
0.05% 163
2020
Q1
$29K Hold
200
0.04% 184
2019
Q4
$34K Hold
200
0.03% 183
2019
Q3
$39K Hold
200
0.04% 189
2019
Q2
$56K Hold
200
0.05% 172
2019
Q1
$57K Hold
200
0.05% 171
2018
Q4
$70K Buy
+200
New +$69.5K 0.07% 161

Other funds holding ABMD

First National Bank of South Miami's ABMD Position: Q4 2022 in Review

First National Bank of South Miami sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 200 shares — an estimated $49K sold.

First National Bank of South Miami first reported a position in ABMD in Q4 2018 and held it in 16 quarters. The position peaked at $72K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • First National Bank of South Miami reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • First National Bank of South Miami sold 200 Abiomed Inc shares in Q4 2022, an estimated $49K.
  • First National Bank of South Miami first reported a position in Abiomed Inc in Q4 2018 and held it in 16 quarters.
  • First National Bank of South Miami's Abiomed Inc position peaked at $72K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on First National Bank of South Miami's 13F filing for Q4 2022, filed 12 Jan 2023.